ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 014

Bone Microarchitecture Impairment in Juvenile Systemic Lupus Erythematosus Patients: A Comparative Study

BEATRIZ ROSA1, Melissa Fraga2, Ana Sakamoto3, Erica Barbosa4, Jade Fernandez4, Marcelo Pinheiro5 and Maria Teresa Terreri6, 1UNIVERSIDADE FEDERAL DE SO PAULO, So Paulo, Brazil, 2Universidade Federal de So Paulo, So Paulo, So Paulo, Brazil, 3Federal University of So Paulo (UNIFESP), So Paulo, Brazil, 4UNIFESP/ EPM, Sao Paulo, Sao Paulo, Brazil, 5UNIFESP/ EPM, So Paulo, Brazil, 6UNIFESP, So Paulo, So Paulo, Brazil

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Clinical and Therapeutic Aspects I

Session Time: 6:00PM-7:00PM

Background/Purpose: Juvenile Systemic Lupus Erythematosus (jSLE) is a multisystem inflammatory disease frequently associated with bone mass loss. This reduction can be assessed through bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA). However, the Trabecular Bone Score (TBS) is a novel, complementary method to BMD that reflects bone microarchitectural quality and contributes to evaluating fragility fracture risk. The primary objective of this study was to assess TBS values derived from DXA scans of children and adolescents diagnosed with jSLE and to compare them with data from age- and sex-matched healthy controls. Secondary objectives included exploring associations between TBS and BMD; identifying risk factors potentially influencing TBS in jSLE—such as clinical parameters and glucocorticoid (GC) use—and assessing the occurrence of fragility fractures.
 

Methods: This was a retrospective observational analytical study including children and adolescents with jSLE aged 5–19 years. Clinical data and BMD values obtained by DXA between 2017 and 2022 at a quaternary care center were analyzed. Patients’ BMD and TBS data were compared with previously published reference data from healthy Brazilian children and adolescents, after appropriate age and sex matching, to facilitate interpretation of potential bone mass reduction.

Results: Ninety-four DXA scans from 50 patients were analyzed. Twenty-one scans showed altered TBS values. Overall, patients with jSLE presented lower TBS scores (mean difference, −0.067 ± 0.113; p < 0.0001). Female patients aged 14–16 and 17–19 years had significantly lower TBS values compared with controls (p < 0.0001 and p = 0.0004, respectively). BMD and TBS were concordant in 80/94 (85.1%) scans, showing a moderate positive correlation (Matthews correlation coefficient ϕ = 0.56; p < 0.0001). TBS values were not associated with disease duration, high disease activity, cumulative GC dose, or occurrence of fragility fractures.

Conclusion: Children and adolescents with jSLE exhibited lower TBS values compared with healthy peers, suggesting impaired bone microarchitecture.


Disclosures: B. ROSA: None; M. Fraga: None; A. Sakamoto: None; E. Barbosa: None; J. Fernandez: None; M. Pinheiro: None; M. Terreri: None.

To cite this abstract in AMA style:

ROSA B, Fraga M, Sakamoto A, Barbosa E, Fernandez J, Pinheiro M, Terreri M. Bone Microarchitecture Impairment in Juvenile Systemic Lupus Erythematosus Patients: A Comparative Study [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/bone-microarchitecture-impairment-in-juvenile-systemic-lupus-erythematosus-patients-a-comparative-study/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-microarchitecture-impairment-in-juvenile-systemic-lupus-erythematosus-patients-a-comparative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology